Vassaki, M., Lazarou, S., Turhanen, P., Choquesillo-Lazarte, D., & Demadis, K. D. (2022). Drug-Inclusive Inorganic–Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate.
Citação norma ChicagoVassaki, Maria, Savvina Lazarou, Petri Turhanen, Duane Choquesillo-Lazarte, y K. D. Demadis. Drug-Inclusive Inorganic–Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate. 2022.
Citação norma MLAVassaki, Maria, et al. Drug-Inclusive Inorganic–Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate. 2022.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.